{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:52Z","timestamp":1786980292030,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702678"],"award-info":[{"award-number":["81702678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103045"],"award-info":[{"award-number":["82103045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-XD202001-0332"],"award-info":[{"award-number":["Y-XD202001-0332"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Opioid-induced nausea and vomiting are frequently observed as an adverse effect in the treatment of cancer-related pain. The factors that affect OINV in cancer patients remain unclear. In this study, we developed a nomogram for predicting the occurrence of OINV in this population using retrospective clinical data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected data from 416 cancer pain patients, 70% of whom used the training set to analyze demographic and clinical variables. We used multivariate logistic regression to identify significant factors associated with OINV. Then, we construct a prediction nomogram. The validation set comprises the remaining 30%. The reliability of the nomogram is evaluated by bootstrap resampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using multivariate logistic regression, we identified five significant factors associated with OINV. The C-index was 0.835 (95% confidence interval [CI], 0.828\u20130.842) for the training set and 0.810 (95% CI, 0.793\u20130.826) for the validation set. The calibrated curves show a good agreement between the predicted and actual occurrence of OINV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In a retrospective study based on five saliency-found variables, we developed and proved a reliable nomogram model to predict OINV in cancer pain patients. Future prospective studies should assess the model\u2019s reliability and usefulness in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-023-08144-0","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T01:07:00Z","timestamp":1698887220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nomogram for predicting opioid-induced nausea and vomiting for cancer pain patients"],"prefix":"10.1007","volume":"31","author":[{"given":"Lingping","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diansheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"16","key":"8144_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127(16):3029\u20133030. https:\/\/doi.org\/10.1002\/cncr.33587","journal-title":"Cancer."},{"issue":"3","key":"8144_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin."},{"key":"8144_CR3","doi-asserted-by":"publisher","first-page":"215814","DOI":"10.1016\/j.canlet.2022.215814","volume":"544","author":"C Zhu","year":"2022","unstructured":"Zhu C, Ma H, He A, Li Y, He C, Xia Y (2022) Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information. Cancer Lett. 544:215814. https:\/\/doi.org\/10.1016\/j.canlet.2022.215814","journal-title":"Cancer Lett."},{"key":"8144_CR4","doi-asserted-by":"publisher","first-page":"215935","DOI":"10.1016\/j.canlet.2022.215935","volume":"551","author":"R Bharti","year":"2022","unstructured":"Bharti R, Dey G, Lin F, Lathia J, Reizes O (2022) CD55 in cancer: Complementing functions in a non-canonical manner. Cancer Lett. 551:215935. https:\/\/doi.org\/10.1016\/j.canlet.2022.215935","journal-title":"Cancer Lett."},{"key":"8144_CR5","doi-asserted-by":"publisher","first-page":"215648","DOI":"10.1016\/j.canlet.2022.215648","volume":"536","author":"S Yu","year":"2022","unstructured":"Yu S, Li W, Tang L, Fan X, Yao S, Zhang X, Bi Z, Cheng H (2022) Depression in breast cancer patients: Immunopathogenesis and immunotherapy. Cancer Lett. 536:215648. https:\/\/doi.org\/10.1016\/j.canlet.2022.215648","journal-title":"Cancer Lett."},{"issue":"6","key":"8144_CR6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ (2016) Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 51(6):1070-1090 e9. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340","journal-title":"J Pain Symptom Manage."},{"issue":"11","key":"8144_CR7","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.ejca.2011.04.014","volume":"47","author":"EA Laugsand","year":"2011","unstructured":"Laugsand EA, Fladvad T, Skorpen F, Maltoni M, Kaasa S, Fayers P, Klepstad P (2011) Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. Eur J Cancer 47(11):1682\u201391. https:\/\/doi.org\/10.1016\/j.ejca.2011.04.014","journal-title":"Eur J Cancer"},{"issue":"1","key":"8144_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/jpm.2018.0260","volume":"22","author":"TA Sande","year":"2019","unstructured":"Sande TA, Laird BJA, Fallon MT (2019) The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review. J Palliat Med 22(1):90\u201397. https:\/\/doi.org\/10.1089\/jpm.2018.0260","journal-title":"J Palliat Med"},{"issue":"2","key":"8144_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0009-9236(03)00152-8","volume":"74","author":"MS Cepeda","year":"2003","unstructured":"Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL (2003) Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther 74(2):102\u201312. https:\/\/doi.org\/10.1016\/S0009-9236(03)00152-8","journal-title":"Clin Pharmacol Ther"},{"issue":"7520","key":"8144_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/bmj.331.7520.825","volume":"331","author":"C Quigley","year":"2005","unstructured":"Quigley C (2005) The role of opioids in cancer pain. BMJ 331(7520):825\u2013829. https:\/\/doi.org\/10.1136\/bmj.331.7520.825","journal-title":"BMJ"},{"issue":"37","key":"8144_CR11","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.2174\/138161212803582540","volume":"18","author":"F Coluzzi","year":"2012","unstructured":"Coluzzi F, Rocco A, Mandatori I, Mattia C (2012) Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation. Curr Pharm Des. 18(37):6043\u201352. https:\/\/doi.org\/10.2174\/138161212803582540","journal-title":"Curr Pharm Des."},{"issue":"5","key":"8144_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/0269216311404273","volume":"25","author":"EA Laugsand","year":"2011","unstructured":"Laugsand EA, Kaasa S, Klepstad P (2011) Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliat Med 25(5):442\u201353. https:\/\/doi.org\/10.1177\/0269216311404273","journal-title":"Palliat Med"},{"issue":"5","key":"8144_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s1526-5900(03)00556-x","volume":"4","author":"E McNicol","year":"2003","unstructured":"McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D, Americal Pain S (2003) Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 4(5):231\u201356. https:\/\/doi.org\/10.1016\/s1526-5900(03)00556-x","journal-title":"J Pain."},{"issue":"6","key":"8144_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/jpm.2013.0613","volume":"17","author":"Y Kanbayashi","year":"2014","unstructured":"Kanbayashi Y, Hosokawa T (2014) Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary? J Palliat Med. 17(6):683\u20137. https:\/\/doi.org\/10.1089\/jpm.2013.0613","journal-title":"J Palliat Med."},{"issue":"3","key":"8144_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00520-019-04884-0","volume":"28","author":"J Sato","year":"2020","unstructured":"Sato J, Tanaka R, Ishikawa H, Suzuki T, Shino M (2020) A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting. Support Care Cancer. 28(3):1083\u20131088. https:\/\/doi.org\/10.1007\/s00520-019-04884-0","journal-title":"Support Care Cancer."},{"issue":"1","key":"8144_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15360288.2020.1829250","volume":"35","author":"Y Ogawa","year":"2021","unstructured":"Ogawa Y, Kurihara T, Sakurai M, Monma M, Nakayama H, Higuchi H, Kogo M, Kiuchi Y (2021) Predictive factors of opioid-induced nausea in cancer patients. J Pain Palliat Care Pharmacother. 35(1):7\u201312. https:\/\/doi.org\/10.1080\/15360288.2020.1829250","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"8144_CR17","doi-asserted-by":"publisher","first-page":"109102","DOI":"10.1016\/j.ejrad.2020.109102","volume":"130","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Ouyang H, Ye F, Chen S, Xie L, Zhao X, Yu X (2020) Multiple mathematical models of diffusion-weighted imaging for endometrial cancer characterization: correlation with prognosis-related risk factors. Eur J Radiol. 130:109102. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109102","journal-title":"Eur J Radiol."},{"issue":"12","key":"8144_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ncpuro0968","volume":"4","author":"MW Kattan","year":"2007","unstructured":"Kattan MW, Scardino PT (2007) Evidence for the usefulness of nomograms. Nat Clin Pract Urol. 4(12):638\u20139. https:\/\/doi.org\/10.1038\/ncpuro0968","journal-title":"Nat Clin Pract Urol."},{"issue":"2","key":"8144_CR19","first-page":"79","volume":"20","author":"MW Kattan","year":"2002","unstructured":"Kattan MW (2002) Nomograms. Introduction Semin Urol Oncol 20(2):79\u201381","journal-title":"Introduction Semin Urol Oncol"},{"key":"8144_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2021.12.015","volume":"527","author":"Q Li","year":"2022","unstructured":"Li Q, Jiang T, Zhang C, Zhang Y, Huang Z, Zhou H, Huang P (2022) A nomogram based on clinical information, conventional ultrasound and radiomics improves prediction of malignant parotid gland lesions. Cancer Lett 527:107\u2013114. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.015","journal-title":"Cancer Lett"},{"issue":"14","key":"8144_CR21","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, McGinn T, Guyatt G (2017) Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA. 318(14):1377\u20131384. https:\/\/doi.org\/10.1001\/jama.2017.12126","journal-title":"JAMA."},{"issue":"1","key":"8144_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12893-023-02064-w","volume":"23","author":"X Zheng","year":"2023","unstructured":"Zheng X, He X (2023) Development of a nomogram for the prediction of complicated appendicitis during pregnancy. BMC Surg. 23(1):188. https:\/\/doi.org\/10.1186\/s12893-023-02064-w","journal-title":"BMC Surg."},{"issue":"6","key":"8144_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 26(6):565\u201374. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Making."},{"issue":"5","key":"8144_CR24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jpainsymman.2019.02.009","volume":"57","author":"O Corli","year":"2019","unstructured":"Corli O, Santucci C, Corsi N, Radrezza S, Galli F, Bosetti C (2019) The burden of opioid adverse events and the influence on cancer patients\u2019 symptomatology. J Pain Symptom Manage. 57(5):899-908 e6. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.02.009","journal-title":"J Pain Symptom Manage."},{"issue":"3","key":"8144_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1634\/theoncologist.2017-0225","volume":"23","author":"H Tsukuura","year":"2018","unstructured":"Tsukuura H, Miyazaki M, Morita T, Sugishita M, Kato H, Murasaki Y, Gyawali B, Kubo Y, Ando M, Kondo M, Yamada K, Hasegawa Y, Ando Y (2018) Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled Double-Blind Trial. Oncologist 23(3):367\u2013374. https:\/\/doi.org\/10.1634\/theoncologist.2017-0225","journal-title":"Oncologist"},{"issue":"1","key":"8144_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00520-016-3371-3","volume":"25","author":"D Walsh","year":"2017","unstructured":"Walsh D, Davis M, Ripamonti C, Bruera E, Davies A, Molassiotis A (2017) 2016 Updated MASCC\/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer. Support Care Cancer. 25(1):333\u2013340. https:\/\/doi.org\/10.1007\/s00520-016-3371-3","journal-title":"Support Care Cancer."},{"issue":"6","key":"8144_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jos.2018.06.011","volume":"23","author":"T Ukai","year":"2018","unstructured":"Ukai T, Ebihara G, Watanabe M (2018) Opioid administration via epidural catheter is a risk factor for postoperative nausea and vomiting in total hip arthroplasty: A retrospective study. J Orthop Sci. 23(6):973\u2013976. https:\/\/doi.org\/10.1016\/j.jos.2018.06.011","journal-title":"J Orthop Sci."},{"issue":"10","key":"8144_CR28","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1007\/s00520-013-1843-2","volume":"21","author":"A Molassiotis","year":"2013","unstructured":"Molassiotis A, Stamataki Z, Kontopantelis E (2013) Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer. 21(10):2759\u201367. https:\/\/doi.org\/10.1007\/s00520-013-1843-2","journal-title":"Support Care Cancer."},{"issue":"8","key":"8144_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/PSY.0000000000000372","volume":"78","author":"D Jung","year":"2016","unstructured":"Jung D, Lee KM, Kim WH, Lee JY, Kim TY, Im SA, Lee KH, Spiegel D, Hahm BJ (2016) Longitudinal association of poor sleep quality with chemotherapy-induced nausea and vomiting in patients with breast cancer. Psychosom Med. 78(8):959\u2013965. https:\/\/doi.org\/10.1097\/PSY.0000000000000372","journal-title":"Psychosom Med."},{"issue":"2","key":"8144_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1620\/tjem.254.111","volume":"254","author":"XJ Huang","year":"2021","unstructured":"Huang XJ, Li XY, Li JH, Hu ZY, Luo L, Tan Y, Chen HY, Fan RR, Wang TY, Meng LQ, Wei T (2021) Nomogram for predicting chemotherapy-induced nausea and vomiting for breast cancer patients. Tohoku J Exp Med. 254(2):111\u2013121. https:\/\/doi.org\/10.1620\/tjem.254.111","journal-title":"Tohoku J Exp Med."},{"issue":"6","key":"8144_CR31","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","volume":"28","author":"G Dranitsaris","year":"2017","unstructured":"Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A, Aapro M (2017) The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Ann Oncol. 28(6):1260\u20131267. https:\/\/doi.org\/10.1093\/annonc\/mdx100","journal-title":"Ann Oncol."},{"issue":"16","key":"8144_CR32","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 95(16):9608\u201313. https:\/\/doi.org\/10.1073\/pnas.95.16.9608","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08144-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08144-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08144-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T05:11:49Z","timestamp":1702530709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08144-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["8144"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08144-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The procedures conducted in studies involving human participants followed the ethical standards of the institutional and\/or national research committee, as well as the 1964 Helsinki Declaration and its subsequent amendments or similar ethical standards. The Medical Ethics Committee of Tianjin Medical University General Hospital approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study obtained informed consent from all individual participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"663"}}